ICD-10 Lookup - Find Medical Diagnosis Codes
ICD-10 Search Results for comp-following-infusion-transfusion-and-theraputc-injection-t80
ICD-10-CM Code | Description | Category | Valid for Submission |
---|---|---|---|
T80 | Complications following infusion, transfusion and therapeutic injection | Not Valid | |
T80.0XXA | Air embolism following infusion, transfusion and therapeutic injection, initial encounter Air embolism as a complication of medical care; Air embolism as a complication of medical care; Air embolism as a complication of medical care; Air embolism complicating intravenous therapy; Air embolism complicating injection; Air embolism due to and following transfusion; Transfusion reaction due to air embolism; Air embolism due to and following transfusion; Air embolism due to and following transfusion; Air embolism complicating injection; | Valid | |
T80.0XXD | Air embolism following infusion, transfusion and therapeutic injection, subsequent encounter Air embolism as a complication of medical care; Air embolism as a complication of medical care; Air embolism as a complication of medical care; Air embolism complicating intravenous therapy; Air embolism complicating injection; Air embolism due to and following transfusion; Transfusion reaction due to air embolism; Air embolism due to and following transfusion; Air embolism due to and following transfusion; Air embolism complicating injection; | Valid | |
T80.0XXS | Air embolism following infusion, transfusion and therapeutic injection, sequela Air embolism as a complication of medical care; Air embolism as a complication of medical care; Air embolism as a complication of medical care; Air embolism complicating intravenous therapy; Air embolism complicating injection; Air embolism due to and following transfusion; Transfusion reaction due to air embolism; Air embolism due to and following transfusion; Air embolism due to and following transfusion; Air embolism complicating injection; | Valid | |
T80.1 | Vascular complications following infusion, transfusion and therapeutic injection | Not Valid | |
T80.1XXA | Vascular complications following infusion, transfusion and therapeutic injection, initial encounter Superficial thrombophlebitis following administration of drug via intravenous route; Necrosis following injection of local anesthetic; Phlebitis following perfusion; Phlebitis following transfusion; Thrombophlebitis following perfusion; Thrombophlebitis following transfusion; Phlebitis after infusion; Thromboembolism after infusion; Thrombophlebitis after infusion; Phlebitis following transfusion; Thrombophlebitis following transfusion; Necrosis following injection of local anesthetic; | Valid | |
T80.1XXD | Vascular complications following infusion, transfusion and therapeutic injection, subsequent encounter Superficial thrombophlebitis following administration of drug via intravenous route; Necrosis following injection of local anesthetic; Phlebitis following perfusion; Phlebitis following transfusion; Thrombophlebitis following perfusion; Thrombophlebitis following transfusion; Phlebitis after infusion; Thromboembolism after infusion; Thrombophlebitis after infusion; Phlebitis following transfusion; Thrombophlebitis following transfusion; Necrosis following injection of local anesthetic; | Valid | |
T80.1XXS | Vascular complications following infusion, transfusion and therapeutic injection, sequela Superficial thrombophlebitis following administration of drug via intravenous route; Necrosis following injection of local anesthetic; Phlebitis following perfusion; Phlebitis following transfusion; Thrombophlebitis following perfusion; Thrombophlebitis following transfusion; Phlebitis after infusion; Thromboembolism after infusion; Thrombophlebitis after infusion; Phlebitis following transfusion; Thrombophlebitis following transfusion; Necrosis following injection of local anesthetic; | Valid | |
T80.8 | Other complications following infusion, transfusion and therapeutic injection | Not Valid | |
T80.89 | Other complications following infusion, transfusion and therapeutic injection | Not Valid | |
T80.89XA | Other complications following infusion, transfusion and therapeutic injection, initial encounter Sclerosing peritonitis as complication of peritoneal dialysis; Hydrothorax as complication of peritoneal dialysis; Abdominal hernia as complication of peritoneal dialysis; Hemoperitoneum as complication of peritoneal dialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Adverse reaction following injection of substance; Extravasation due to and following blood transfusion; Thromboembolism following infusion, perfusion AND/OR transfusion; Polycythemia neonatorum following blood transfusion; Neonatal hyperbilirubinemia following total parenteral nutrition; Osteonecrosis due to and following renal dialysis; Injury due to and following infusion; Injury due to and following transfusion; Injury due to and following therapeutic injection; Mechanical failure of instrument or apparatus during infusion or transfusion; Air in infusion or transfusion due to mechanical failure of apparatus; Thromboembolism following infusion, perfusion AND/OR transfusion; Injury due to and following infusion; Infusion site swelling; Alloimmune platelet transfusion refractoriness; Mechanical failure of instrument or apparatus during infusion or transfusion; Pulmonary transfusion reaction; Air in infusion or transfusion due to mechanical failure of apparatus; Erythrocytosis due to autotransfusion; Urticarial transfusion reaction; Transfusion reaction due to products of cell metabolism; Extravasation due to and following blood transfusion; Allergic transfusion reaction; Hemolytic transfusion reaction; Thromboembolism following infusion, perfusion AND/OR transfusion; Transfusion reaction due to toxic effect of anticoagulant; Transfusion hemosiderosis; Transfusion reaction due to toxic substance in blood; Polycythemia neonatorum following blood transfusion; Injury due to and following transfusion; Extravasation due to and following blood transfusion; Thromboembolism following infusion, perfusion AND/OR transfusion; Chronic kidney disease mineral and bone disorder; Osteonecrosis due to and following renal dialysis; Injury due to and following infusion; Injury due to and following transfusion; Injury due to and following therapeutic injection; Adverse reaction following injection of substance; Myelopathy post intrathecal injection of chemotherapeutic agent; Erythema at injection site; Swelling at injection site; Injection neuropathy; Injury due to and following therapeutic injection; Injection site itching; Injection site cellulitis; Injection site indentation; Blister at injection site; Injection site eruption; Injection site eruption; Injection site pruritus; Injection site hypersensitivity; Injection site irritation; Injection site pigmentation change; Injection site hemorrhage; Injection site thrombosis; Injection site malabsorption; Injection site pain; Injection site burning; Injection site nerve damage; Injection site inflammation; Injection site inflammation; Injection site inflammation; Injection site edema; Injection site edema; Injection site dermatitis; Injection site urticaria; Injection site mass; Injection site mass; Injection site cyst; Injection site necrosis; Injection site anesthesia; Injection site paresthesia; Injection site bruising; Injection site induration; Injection site fibrosis; Injection site atrophy; | Valid | |
T80.89XD | Other complications following infusion, transfusion and therapeutic injection, subsequent encounter Sclerosing peritonitis as complication of peritoneal dialysis; Hydrothorax as complication of peritoneal dialysis; Abdominal hernia as complication of peritoneal dialysis; Hemoperitoneum as complication of peritoneal dialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Adverse reaction following injection of substance; Extravasation due to and following blood transfusion; Thromboembolism following infusion, perfusion AND/OR transfusion; Polycythemia neonatorum following blood transfusion; Neonatal hyperbilirubinemia following total parenteral nutrition; Osteonecrosis due to and following renal dialysis; Injury due to and following infusion; Injury due to and following transfusion; Injury due to and following therapeutic injection; Mechanical failure of instrument or apparatus during infusion or transfusion; Air in infusion or transfusion due to mechanical failure of apparatus; Thromboembolism following infusion, perfusion AND/OR transfusion; Injury due to and following infusion; Infusion site swelling; Alloimmune platelet transfusion refractoriness; Mechanical failure of instrument or apparatus during infusion or transfusion; Pulmonary transfusion reaction; Air in infusion or transfusion due to mechanical failure of apparatus; Erythrocytosis due to autotransfusion; Urticarial transfusion reaction; Transfusion reaction due to products of cell metabolism; Extravasation due to and following blood transfusion; Allergic transfusion reaction; Hemolytic transfusion reaction; Thromboembolism following infusion, perfusion AND/OR transfusion; Transfusion reaction due to toxic effect of anticoagulant; Transfusion hemosiderosis; Transfusion reaction due to toxic substance in blood; Polycythemia neonatorum following blood transfusion; Injury due to and following transfusion; Extravasation due to and following blood transfusion; Thromboembolism following infusion, perfusion AND/OR transfusion; Chronic kidney disease mineral and bone disorder; Osteonecrosis due to and following renal dialysis; Injury due to and following infusion; Injury due to and following transfusion; Injury due to and following therapeutic injection; Adverse reaction following injection of substance; Myelopathy post intrathecal injection of chemotherapeutic agent; Erythema at injection site; Swelling at injection site; Injection neuropathy; Injury due to and following therapeutic injection; Injection site itching; Injection site cellulitis; Injection site indentation; Blister at injection site; Injection site eruption; Injection site eruption; Injection site pruritus; Injection site hypersensitivity; Injection site irritation; Injection site pigmentation change; Injection site hemorrhage; Injection site thrombosis; Injection site malabsorption; Injection site pain; Injection site burning; Injection site nerve damage; Injection site inflammation; Injection site inflammation; Injection site inflammation; Injection site edema; Injection site edema; Injection site dermatitis; Injection site urticaria; Injection site mass; Injection site mass; Injection site cyst; Injection site necrosis; Injection site anesthesia; Injection site paresthesia; Injection site bruising; Injection site induration; Injection site fibrosis; Injection site atrophy; | Valid | |
T80.89XS | Other complications following infusion, transfusion and therapeutic injection, sequela Sclerosing peritonitis as complication of peritoneal dialysis; Hydrothorax as complication of peritoneal dialysis; Abdominal hernia as complication of peritoneal dialysis; Hemoperitoneum as complication of peritoneal dialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Complication of hemodialysis; Adverse reaction following injection of substance; Extravasation due to and following blood transfusion; Thromboembolism following infusion, perfusion AND/OR transfusion; Polycythemia neonatorum following blood transfusion; Neonatal hyperbilirubinemia following total parenteral nutrition; Osteonecrosis due to and following renal dialysis; Injury due to and following infusion; Injury due to and following transfusion; Injury due to and following therapeutic injection; Mechanical failure of instrument or apparatus during infusion or transfusion; Air in infusion or transfusion due to mechanical failure of apparatus; Thromboembolism following infusion, perfusion AND/OR transfusion; Injury due to and following infusion; Infusion site swelling; Alloimmune platelet transfusion refractoriness; Mechanical failure of instrument or apparatus during infusion or transfusion; Pulmonary transfusion reaction; Air in infusion or transfusion due to mechanical failure of apparatus; Erythrocytosis due to autotransfusion; Urticarial transfusion reaction; Transfusion reaction due to products of cell metabolism; Extravasation due to and following blood transfusion; Allergic transfusion reaction; Hemolytic transfusion reaction; Thromboembolism following infusion, perfusion AND/OR transfusion; Transfusion reaction due to toxic effect of anticoagulant; Transfusion hemosiderosis; Transfusion reaction due to toxic substance in blood; Polycythemia neonatorum following blood transfusion; Injury due to and following transfusion; Extravasation due to and following blood transfusion; Thromboembolism following infusion, perfusion AND/OR transfusion; Chronic kidney disease mineral and bone disorder; Osteonecrosis due to and following renal dialysis; Injury due to and following infusion; Injury due to and following transfusion; Injury due to and following therapeutic injection; Adverse reaction following injection of substance; Myelopathy post intrathecal injection of chemotherapeutic agent; Erythema at injection site; Swelling at injection site; Injection neuropathy; Injury due to and following therapeutic injection; Injection site itching; Injection site cellulitis; Injection site indentation; Blister at injection site; Injection site eruption; Injection site eruption; Injection site pruritus; Injection site hypersensitivity; Injection site irritation; Injection site pigmentation change; Injection site hemorrhage; Injection site thrombosis; Injection site malabsorption; Injection site pain; Injection site burning; Injection site nerve damage; Injection site inflammation; Injection site inflammation; Injection site inflammation; Injection site edema; Injection site edema; Injection site dermatitis; Injection site urticaria; Injection site mass; Injection site mass; Injection site cyst; Injection site necrosis; Injection site anesthesia; Injection site paresthesia; Injection site bruising; Injection site induration; Injection site fibrosis; Injection site atrophy; | Valid | |
T80.9 | Unspecified complication following infusion, transfusion and therapeutic injection | Not Valid |